ROVI and the EIB agreement

ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies


No votes yet
 
Relacionados
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) ha anunciado la compra de Falithrom®, propiedad de Hexal AG (“Hexal”), una compañía de la...
1 min
09/01/2019